Search research articles
Contact Us
Filters
Showing results (71-80 of 163) with videos related to
Page
of 17
Sort By:
American Journal of Hematology
|
November 19, 2022
Refractory idiopathic multicentric Castleman disease responsive to sirolimus therapy
Ertugrul Bayram, Umur Anil Pehlivan, David C Fajgenbaum, et al.
Leukemia & Lymphoma
|
February 13, 2004
Successful rituximab therapy for hemolytic anemia associated with relapsed splenic marginal zone lymphoma with leukemic phase
Semra Paydas, Sinan Yavuz, Umut Disel, et al.
Advances in Therapy
|
January 19, 2006
VEGF-C expression in breast cancer: clinical importance
Sinan Yavuz, Semra Paydas, Umut Disel, et al.
Annals of Hematology
|
May 26, 2015
Programmed death-1 (PD-1), programmed death-ligand 1 (PD-L1), and EBV-encoded RNA (EBER) expression in Hodgkin lymphoma
Semra Paydas, Emine Bağır, Gulsah Seydaoglu, et al.
Journal of Gastrointestinal Cancer
|
March 19, 2020
The Effect of Inflammatory Markers on Survival in Advanced Biliary Tract Carcinoma Treated with Gemcitabine/Oxaliplatin Regimen
Mahmut Buyuksimsek, Mehmet Mutlu Kidi, Ali Ogul, et al.
Journal of Clinical Pathology
|
February 14, 2018
PD-1 and PD-L1 expression in thymic epithelial tumours and non-neoplastic thymus
Emine Kilic Bagir, Arbil Acikalin, Alper Avci, et al.
European Journal of Mass Spectrometry (Chichester, England)
|
May 3, 2022
GC-MS based metabolite fingerprinting of serous ovarian carcinoma and benign ovarian tumor
Evren Caglar Eroglu, Umran Kucukgoz Gulec, Mehmet Ali Vardar, et al.
Leukemia & Lymphoma
|
February 15, 2012
Secondary malignancy after imatinib therapy: eight cases and review of the literature
Berna Bozkurt Duman, Semra Paydas, Umut Disel, et al.
Mycoses
|
February 20, 2007
Amphotericin B deoxycholate (d-AMB) use in cases with febrile neutropenia and fungal infections: lower toxicity with suitable premedication
Ozgur Akin Oto, Semra Paydas, Umut Disel, et al.
European Journal of Internal Medicine
|
October 30, 2012
Energy drinks and chemotherapy: can these products cause detrimental effects in cancer patients receiving chemotherapy?
Semra Paydas, Yusuf Sonay, Arbil Avci, et al.
Page
of 17
Search research articles
Search
Showing results (71-80 of 163) with videos related to
Sort By:
Page
of 17
American Journal of Hematology
|
November 19, 2022
Refractory idiopathic multicentric Castleman disease responsive to sirolimus therapy
Ertugrul Bayram, Umur Anil Pehlivan, David C Fajgenbaum, et al.
Leukemia & Lymphoma
|
February 13, 2004
Successful rituximab therapy for hemolytic anemia associated with relapsed splenic marginal zone lymphoma with leukemic phase
Semra Paydas, Sinan Yavuz, Umut Disel, et al.
Advances in Therapy
|
January 19, 2006
VEGF-C expression in breast cancer: clinical importance
Sinan Yavuz, Semra Paydas, Umut Disel, et al.
Annals of Hematology
|
May 26, 2015
Programmed death-1 (PD-1), programmed death-ligand 1 (PD-L1), and EBV-encoded RNA (EBER) expression in Hodgkin lymphoma
Semra Paydas, Emine Bağır, Gulsah Seydaoglu, et al.
Journal of Gastrointestinal Cancer
|
March 19, 2020
The Effect of Inflammatory Markers on Survival in Advanced Biliary Tract Carcinoma Treated with Gemcitabine/Oxaliplatin Regimen
Mahmut Buyuksimsek, Mehmet Mutlu Kidi, Ali Ogul, et al.
Journal of Clinical Pathology
|
February 14, 2018
PD-1 and PD-L1 expression in thymic epithelial tumours and non-neoplastic thymus
Emine Kilic Bagir, Arbil Acikalin, Alper Avci, et al.
European Journal of Mass Spectrometry (Chichester, England)
|
May 3, 2022
GC-MS based metabolite fingerprinting of serous ovarian carcinoma and benign ovarian tumor
Evren Caglar Eroglu, Umran Kucukgoz Gulec, Mehmet Ali Vardar, et al.
Leukemia & Lymphoma
|
February 15, 2012
Secondary malignancy after imatinib therapy: eight cases and review of the literature
Berna Bozkurt Duman, Semra Paydas, Umut Disel, et al.
Mycoses
|
February 20, 2007
Amphotericin B deoxycholate (d-AMB) use in cases with febrile neutropenia and fungal infections: lower toxicity with suitable premedication
Ozgur Akin Oto, Semra Paydas, Umut Disel, et al.
European Journal of Internal Medicine
|
October 30, 2012
Energy drinks and chemotherapy: can these products cause detrimental effects in cancer patients receiving chemotherapy?
Semra Paydas, Yusuf Sonay, Arbil Avci, et al.
Page
of 17